Israel Englander Charles River Laboratories International, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 21,000 shares of CRL stock, worth $4.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,000

Previous 136,060 84.57%

Holding current value

$4.33 Million

Previous $36.9 Million 88.23%

% of portfolio

0.0%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $25.7 Million - $33.5 Million	-124,737 Reduced 91.68%	11,323 $2.34 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $16.9 Million - $22.7 Million	83,201 Added 157.4%	136,060 $36.9 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $10.1 Million - $14.7 Million	-61,444 Reduced 53.76%	52,859 $12.5 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $830,001 - $949,909	4,518 Added 4.12%	114,303 $24 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $62.9 Million - $85.3 Million	-328,002 Reduced 74.92%	109,785 $22.2 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $86.3 Million - $109 Million	437,787 New	437,787 $95.4 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $46.8 Million - $69.3 Million	-229,111 Reduced 98.89%	2,568 $549,000
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $4 Million - $5.67 Million	15,668 Added 7.25%	231,679 $65.8 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $2.87 Million - $3.66 Million	-8,166 Reduced 3.64%	216,011 $81.4 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $41.5 Million - $51 Million	111,271 Added 98.55%	224,177 $92.5 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $20.9 Million - $26.4 Million	-71,105 Reduced 38.64%	112,906 $41.8 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $44 Million - $52.8 Million	-176,399 Reduced 48.94%	184,011 $53.3 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $8.79 Million - $10 Million	39,573 Added 12.33%	360,410 $90.1 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $5.68 Million - $7.33 Million	32,378 Added 11.22%	320,837 $72.7 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $17.6 Million - $28 Million	147,687 Added 104.91%	288,459 $50.3 Million
Q1 2020 May 14, 2020	SELL	$98.9 - $178.34 $32.7 Million - $59 Million	-330,998 Reduced 70.16%	140,772 $17.8 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $58.2 Million - $70.5 Million	461,780 Added 4622.42%	471,770 $72.1 Million
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $47.8 Million - $54.9 Million	-382,101 Reduced 97.45%	9,990 $1.32 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $31.6 Million - $38 Million	-255,800 Reduced 39.48%	392,091 $55.6 Million
Q1 2019 May 14, 2019	BUY	$104.82 - $146.73 $46.8 Million - $65.6 Million	446,792 Added 222.18%	647,891 $94.1 Million
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $20.2 Million - $26.4 Million	192,669 Added 2285.52%	201,099 $22.8 Million
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $1.88 Million - $2.25 Million	-16,749 Reduced 66.52%	8,430 $1.13 Million
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $33.9 Million - $38.8 Million	-330,708 Reduced 92.93%	25,179 $2.83 Million
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $34.4 Million - $40.4 Million	350,454 Added 6450.47%	355,887 $38 Million
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $21.7 Million - $25.6 Million	-216,504 Reduced 97.55%	5,433 $595,000
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $21.5 Million - $24.2 Million	221,937	221,937 $24 Million

Others Institutions Holding CRL

# of Institutions

732

Shares Held

51.8M

Call Options Held

233K

Put Options Held

236K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.5B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account